MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with L

Linezolid

Linezolid 600mg tablets

Compatible

Stability notes for Linezolid 600mg tablets

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Zyvox 600mg tablets (Pfizer Ltd).

Suppliers (9) of Linezolid 600mg tablets
Linezolid 600mg tablets (A A H Pharmaceuticals Ltd)
Linezolid 600mg tablets (Accord-UK Ltd)
Linezolid 600mg tablets (Alliance Healthcare (Distribution) Ltd)
Linezolid 600mg tablets (Amarox Ltd)
Linezolid 600mg tablets (Genus Pharmaceuticals Ltd)
Linezolid 600mg tablets (Medihealth (Northern) Ltd)
Linezolid 600mg tablets (Pfizer Ltd)
Linezolid 600mg tablets (Sandoz Ltd)
Zyvox 600mg tablets (Pfizer Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.